Astellas Pharma Inc
TSE:4503

Watchlist Manager
Astellas Pharma Inc Logo
Astellas Pharma Inc
TSE:4503
Watchlist
Price: 2 007 JPY 0.35% Market Closed
Market Cap: 3.6T JPY

Intrinsic Value

The intrinsic value of one Astellas Pharma Inc stock under the Base Case scenario is hidden JPY. Compared to the current market price of 2 007 JPY, Astellas Pharma Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

Astellas Pharma Inc Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Astellas Pharma Inc

Intrinsic Value History
Dive into the past to invest in the future

Astellas Pharma Inc looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether Astellas Pharma Inc usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about Astellas Pharma Inc?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Astellas Pharma Inc valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Astellas Pharma Inc.

Explain Valuation
Compare Astellas Pharma Inc to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Astellas Pharma Inc?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Astellas Pharma Inc

Current Assets 1.4T
Cash & Short-Term Investments 295.7B
Receivables 716.4B
Other Current Assets 356.7B
Non-Current Assets 2.1T
Long-Term Investments 130.3B
PP&E 334.2B
Intangibles 1.5T
Other Non-Current Assets 162.9B
Current Liabilities 1.3T
Accounts Payable 168.7B
Other Current Liabilities 1.2T
Non-Current Liabilities 512.4B
Long-Term Debt 320B
Other Non-Current Liabilities 192.4B
Efficiency

Free Cash Flow Analysis
Astellas Pharma Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Astellas Pharma Inc

Revenue
2T JPY
Cost of Revenue
-375.7B JPY
Gross Profit
1.6T JPY
Operating Expenses
-1.5T JPY
Operating Income
145.8B JPY
Other Expenses
-21B JPY
Net Income
124.9B JPY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Astellas Pharma Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Gross Margin is Increasing
Low 3Y Average Operating Margin
hidden
Profitability
Score

Astellas Pharma Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Astellas Pharma Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Positive Net Debt
Short-Term Solvency
hidden
Solvency
Score

Astellas Pharma Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Astellas Pharma Inc

Wall Street analysts forecast Astellas Pharma Inc stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Astellas Pharma Inc is 1 879.15 JPY with a low forecast of 1 313 JPY and a high forecast of 2 520 JPY.

Lowest
Price Target
1 313 JPY
35% Downside
Average
Price Target
1 879.15 JPY
6% Downside
Highest
Price Target
2 520 JPY
26% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Astellas Pharma Inc is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

News

Other Videos
What is the Intrinsic Value of one Astellas Pharma Inc stock?

The intrinsic value of one Astellas Pharma Inc stock under the Base Case scenario is hidden JPY.

Is Astellas Pharma Inc stock undervalued or overvalued?

Compared to the current market price of 2 007 JPY, Astellas Pharma Inc is hidden .

Back to Top